Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
05/14/2003 | EP1309551A1 Indoline derivatives as 5ht2c antagonists |
05/14/2003 | EP1309544A1 Compounds acting as melanocortin receptor ligands |
05/14/2003 | EP1200403B1 Process for the preparation of spiro(cis-4-(beta-hydroxyethyloxy) cyclohexane-(3h) indol)-2'(1'h)-one derivatives |
05/14/2003 | CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound |
05/14/2003 | CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same |
05/14/2003 | CN1418187A Carboxylic acid derivatives as IP antagonists |
05/14/2003 | CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina |
05/14/2003 | CN1418100A Compounds with 5-HT activity useful for controlling visual field loss |
05/14/2003 | CN1418099A Choice compound for treatment of fibromyalgia and chronic fatigue syndrome |
05/14/2003 | CN1418089A Pharmaceutical composition of glycogen phosphorylase inhibitors |
05/14/2003 | CN1108291C Method for preparing substituted perhydroisoindole |
05/14/2003 | CN1108290C Urea derivatives |
05/13/2003 | US6563003 Process to produce amino alcohol salts |
05/13/2003 | US6562983 Process for the preparation of alkyl 4[2-(phthalimido)ethoxy]-acetoacetate |
05/13/2003 | US6562982 Carbazole compounds |
05/13/2003 | US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
05/13/2003 | CA2219115C N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs |
05/08/2003 | WO2003037864A1 Indole compound and medicinal use thereof |
05/08/2003 | WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain |
05/08/2003 | WO2003037862A1 Amide derivatives and drugs |
05/08/2003 | WO2003037861A1 Use of 2-acylindoles in the treatment of tumors |
05/08/2003 | WO2003037338A2 Modulators of the cholesterol biosynthetic pathway |
05/08/2003 | WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
05/08/2003 | WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents |
05/08/2003 | WO2002048097A9 Compounds, compositions and methods for treatment of parasitic infections |
05/08/2003 | WO2002009702A8 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
05/08/2003 | US20030088099 Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia |
05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
05/08/2003 | US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents |
05/08/2003 | US20030087901 Compounds and methods for modulation of estrogen receptors |
05/08/2003 | US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders. |
05/08/2003 | US20030087762 Auxinic analogues of indole-3-acetic acid |
05/08/2003 | US20030087306 Methods for identifying novel multimeric agents that modulate receptors |
05/08/2003 | US20030086666 Novel nonlinear optical polymers incorporating amines |
05/08/2003 | US20030085388 Novel nonlinear optical compounds and polymers |
05/08/2003 | CA2466032A1 Methods and dosage forms for improving the bioavailability of therapeutic agents |
05/08/2003 | CA2465382A1 Indole compound and medicinal use thereof |
05/08/2003 | CA2465236A1 Substituted indoles, method for production and use thereof for the inhibition of pain |
05/07/2003 | EP1308438A1 3-substituted urea derivatives and medicinal use thereof |
05/07/2003 | EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
05/07/2003 | EP1140825B1 Melatonin derivatives and medicine containing same |
05/07/2003 | EP1029297B1 Method of virtual retrieval of analogs of lead compounds |
05/07/2003 | EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
05/07/2003 | EP0938491B1 Heterocyclic metallocenes and polymerization catalysts |
05/07/2003 | EP0912510B1 Nickel catalyzed addition of -nh- containing compounds to vinyl and aryl halides |
05/07/2003 | EP0799219B1 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
05/07/2003 | CN1416022A Electronic photograph organic photoreceptor having novel charge migration compound |
05/07/2003 | CN1415618A Compound possessing function for preventing and curing thrombus disease, its pharmacy compsn. and usage in medication |
05/07/2003 | CN1415617A Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science |
05/07/2003 | CN1415605A Method for preparing N-ethyl carbazole |
05/07/2003 | CN1415596A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science |
05/07/2003 | CN1107677C Camptothecin derivatives and use thereof as antimutor agents |
05/06/2003 | US6559318 Hydrolysis of 1,1,3,3-tetraalkoxyalkane to 3,3-dialkoxypropionaldehyde using acid catalyst; Henry reaction with nitromethane; dehydration, Diels-Alder reaction, hydrogenation, cyanation, saponification |
05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
05/06/2003 | US6559171 Muscarinic receptor modulators 7-oxo-2-azabicyclo(2.2.1)heptanes of formula (I) which are useful for the treatment of various diseases and conditions, for example, Alzheimer's disease, glaucoma, psychosis, |
05/06/2003 | CA2056068C Process |
05/06/2003 | CA2032864C Peptide compounds, a process for preparation thereof and pharmaceutical composition comprising the same |
05/02/2003 | EP1306367A1 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
05/02/2003 | EP1305318A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo 2,1-b] 1,3]benzotiazepines |
05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
05/02/2003 | EP1305286A2 Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
05/02/2003 | EP1305285A1 N-substituted indoles useful in the treatment of diabetes |
05/02/2003 | EP1305278A1 Ruthenium complexes and their use in asymmetric hydrogenation |
05/02/2003 | EP1200404B1 Process for the preparation of spiro[(4-cyclohexanone)- [3h] indol-2'[1'h]-one derivatives |
05/02/2003 | EP0988035B1 Caspases and apoptosis |
05/02/2003 | EP0918761B1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
05/02/2003 | EP0854874B1 Macrocyclic lactone compounds and their production process |
05/02/2003 | EP0831799B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
05/02/2003 | EP0786988B1 Use of nk1 receptor antagonists for preparing cardio-regulatory drugs |
05/02/2003 | EP0772592B1 1H-INDOLE-1-FUNCTIONAL sPLA 2 INHIBITORS |
05/01/2003 | WO2003035622A1 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
05/01/2003 | WO2003035621A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
05/01/2003 | WO2003035620A1 Bicyclic compound |
05/01/2003 | WO2003035602A1 Lipid modulators |
05/01/2003 | WO2003035061A1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
05/01/2003 | WO2003005970A3 Carvedilol polymorph |
05/01/2003 | US20030083523 Amide derivatives |
05/01/2003 | US20030083506 Methyl 2-(3-chloropropoxy)-indole-3-carboxylate by reacting a 3-chloro-3-carboxylate indole compound with 3-chloropropanol in the presence of an acid having a pKa of 0-2 e.g., trifluoroacetic acid (not methanesulfonic acid); efficiency |
05/01/2003 | US20030083504 N- (4-carbamimidoyl-phenyl) -glycine derivatives |
05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
05/01/2003 | US20030083336 Dopamine D4 receptor ligands; treating psychosis, schizophrenia and affective disorders |
05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
05/01/2003 | US20030083269 Nictoinamide adenine dinucleotide (NAD); microbiocides; antiseptics; plant safening agents; antibiotic resistance; agriculture; food treatment |
05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
05/01/2003 | US20030083202 Roots-inducing agent of plants and its treatment method |
05/01/2003 | US20030082631 Detecting modulator of peroxisome proliferator-activated receptor; obtain sample contain proxisome receptor, incubate with test agent, monitor sample for adjustment in receptor activity |
05/01/2003 | US20030079301 Agent for dyeing fibers comprising an indoline/indolium derivative |
04/30/2003 | CN1414956A Substituted piperazine derivatives as MIP inhibitors |
04/30/2003 | CN1414848A Prevention of plaque rupure by ACAT inhibitors |
04/30/2003 | CN1414060A Electro Chromotropic solution containing hydrazone compound and its electro chromotropic apparatus |
04/30/2003 | CN1413990A Epimino substituted benzene derivative |
04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
04/30/2003 | CN1107053C Preparation method of 2,2'-bi (N-methyl phthalimide-4-oxy phenyl) propane |
04/29/2003 | WO2002036117A1 Medicinal compositions for concominant use as anticancer atent |
04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
04/29/2003 | US6555664 Phthalimidyl azo pigments, method for producing same and utilisation thereof |
04/29/2003 | US6555568 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid, ethyl ester for example; treating angiogenesis, hyperglycemia, hyperlipidemia and chronic complications arising from diabetes mellitus |
04/29/2003 | US6555550 Musarinic agonists and antagonists |